Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Sulfo-Cy7 NHS Ester: Advanced Near-Infrared Dye for Prote...

    2026-01-30

    Sulfo-Cy7 NHS Ester: Accelerating Near-Infrared Protein Labeling for Translational Research

    Principle and Setup: The Science Behind Sulfo-Cy7 NHS Ester

    Modern life science research increasingly relies on high-fidelity fluorescent probes for mapping biomolecular dynamics in complex biological systems. Sulfo-Cy7 NHS Ester from APExBIO represents a next-generation solution, designed as a sulfonated near-infrared fluorescent dye with exceptional water solubility and minimized fluorescence quenching. Its NHS (N-hydroxysuccinimide) ester functionality enables rapid and efficient conjugation to primary amino groups on proteins, peptides, and other biomolecules, forming stable covalent bonds while preserving native structure and function.

    This amino group labeling reagent stands out due to its optimized excitation and emission maxima (750/773 nm), a high extinction coefficient of 240,600 M⁻¹cm⁻¹, and a quantum yield of 0.36. These features collectively support sensitive detection and quantitation of labeled targets, even in highly autofluorescent or opaque tissue environments. The dye’s sulfonate groups confer impressive hydrophilicity, virtually eliminating the need for organic co-solvents and reducing protein denaturation risk—critical when working with fragile samples such as membrane vesicles, extracellular vesicles, or labile protein complexes.

    Why Near-Infrared Labeling?

    Near-infrared (NIR) fluorescent imaging capitalizes on the tissue transparency window, where light penetration is maximized, and background interference is minimized. Sulfo-Cy7 NHS Ester’s spectral profile allows researchers to non-destructively monitor labeled molecules in live organisms, enabling advanced tissue transparency imaging and improving the signal-to-noise ratio in deep-tissue studies.

    Step-by-Step Workflow: Optimizing Protein & Vesicle Labeling

    Implementing Sulfo-Cy7 NHS Ester in your experimental pipeline is straightforward, but optimal results hinge on careful protocol design. Here’s a best-practice workflow for labeling proteins, peptides, or extracellular vesicles:

    1. Sample Preparation
      Buffer exchange into a primary amine-free buffer (e.g., PBS or sodium bicarbonate, pH 7.5–8.5) to avoid competing reactions. Remove amine-containing stabilizers (e.g., Tris, glycine) by dialysis or ultrafiltration.
    2. Dye Reconstitution
      Dissolve Sulfo-Cy7 NHS Ester in water, DMF, or DMSO to prepare a concentrated stock. For protein labeling, use freshly prepared aqueous solutions to maximize activity and avoid hydrolysis of the NHS ester.
    3. Conjugation Reaction
      Add dye solution to the target biomolecule at a 5–20-fold molar excess. Incubate at room temperature (20–25°C) for 30–60 minutes, protected from light. The aqueous compatibility prevents protein denaturation and preserves vesicle integrity.
    4. Quenching & Purification
      Terminate the reaction by adding excess Tris or glycine, then remove unreacted dye using size-exclusion chromatography or spin columns. This step is essential for reducing background fluorescence in downstream imaging.
    5. Validation & Storage
      Characterize labeling efficiency by UV-Vis spectroscopy (A280 and A750), SDS-PAGE fluorescence scanning, or functional assays. Store labeled products at 4°C in the dark; avoid long-term storage of dye solutions due to hydrolytic instability.

    This streamlined protocol ensures reproducible, high-sensitivity labeling for diverse applications, from in vitro assays to whole-animal imaging.

    Advanced Applications: Illuminating Complex Biological Interactions

    The unique features of Sulfo-Cy7 NHS Ester open new avenues for translational and mechanistic research. In a landmark study (Zha et al., 2024), researchers investigated the role of Clostridium difficile-derived membrane vesicles (MVs) in fetal growth restriction (FGR). Tracking the biodistribution and cellular uptake of bacterial MVs in vivo hinges on robust, non-perturbing labeling strategies. Sulfo-Cy7 NHS Ester, as a near-infrared dye for bioimaging, enables high-fidelity mapping of vesicle trafficking within live tissues—even through the placenta—thanks to its deep-penetrating fluorescence and minimized quenching.

    Compared to traditional protein labeling dyes, Sulfo-Cy7 NHS Ester’s hydrophilicity and resistance to self-quenching ensure quantitative, reproducible results in live cell imaging and deep-tissue studies, as highlighted in "Sulfo-Cy7 NHS Ester: Precision Protein Labeling for Next-Gen Imaging". This makes it ideal for tracking delicate vesicles and protein complexes implicated in disease pathogenesis, such as the MVs shown to alter placental function via the PPARγ/RXRα/ANGPTL4 axis in FGR models.

    Comparative Advantages and Interlinked Insights

    Troubleshooting and Optimization: Maximizing Labeling Success

    For researchers venturing into complex labeling experiments, a few troubleshooting strategies can ensure optimal outcomes:

    • Low Labeling Efficiency: Confirm buffer conditions (pH 7.5–8.5) and absence of competing amines. Adjust dye-to-protein ratio and reaction time as needed.
    • Protein Aggregation or Loss of Activity: Leverage the dye’s water solubility to avoid organic co-solvents. For sensitive proteins or vesicles, keep reaction times short and temperatures moderate.
    • High Background Fluorescence: Purify extensively to remove unreacted dye. Validate with control samples to ensure specificity.
    • Signal Instability or Quenching: Protect labeled samples from prolonged light exposure and store at 4°C in the dark. Sulfonate-mediated quenching reduction is a hallmark, but overlabeling can still cause some quenching—optimize the degree of labeling for your application.
    • Sample Storage: While the dye itself is stable for up to 24 months at –20°C desiccated and in the dark, avoid storing labeled biomolecule solutions for extended periods; use promptly for best results.

    These guidelines are distilled from both product documentation and best practices reported in recent literature, including quantitative imaging studies in live animal models (Sulfo-Cy7 NHS Ester: Advancing Near-Infrared Protein Labeling).

    Future Outlook: Expanding the Frontier of Biomolecule Imaging

    The role of sulfonated near-infrared fluorescent dyes like Sulfo-Cy7 NHS Ester is set to expand as researchers tackle increasingly complex biological questions. Whether elucidating the mechanisms by which bacterial vesicles mediate placental dysfunction or mapping cell-to-cell communication in real time, advanced protein labeling dyes will be indispensable for quantitative, high-resolution imaging.

    Emerging applications include multiplexed imaging of different biomolecule populations, integration with super-resolution microscopy, and in vivo tracking of dynamic events in translational disease models. As highlighted by the referenced FGR study and complementary resources, the ability to monitor vesicle trafficking and signaling cascades in live tissues opens new diagnostic and therapeutic avenues.

    For laboratories seeking reliability, scalability, and translational impact, APExBIO’s Sulfo-Cy7 NHS Ester is positioned as a trusted, high-performance solution—backed by robust technical support and a growing body of peer-reviewed validation.

    Conclusion

    Sulfo-Cy7 NHS Ester exemplifies the next generation of fluorescent probes for biomolecule conjugation, offering unrivaled water solubility, fluorescence quenching reduction, and sensitivity in near-infrared fluorescent imaging. By enabling non-destructive, high-contrast visualization in live-cell and deep-tissue contexts, it is catalyzing discoveries at the frontiers of molecular and translational research. For further details, visit the official Sulfo-Cy7 NHS Ester product page.